Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Redman

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Characterization of a recurrent novel large duplication in the cystic fibrosis transmembrane conductance regulator geneFeras M Hantash, Joy B Redman, Dana Goos, et al.
Anti-Cancer Drugs|June 1, 1995
The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphomaA Maki, H Diwakaran, B Redman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 17, 2007
Molecular testing for Fragile X Syndrome: lessons learned from 119,232 tests performed in a clinical laboratoryCharles M Strom, Beryl Crossley, Joy B Redman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2014
A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinomaB Rini, B Redman, J A Garcia, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 12, 2010
Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysisCharles M Strom, Beryl Crossley, Arlene Buller-Buerkle, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Identification of cystic fibrosis variants by polymerase chain reaction/oligonucleotide ligation assayKaren M Schwartz, Lisa L Pike-Buchanan, Kasinathan Muralidharan, et al.
Human Genetics|December 20, 2005
Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screeningFeras M Hantash, Joy B Redman, Kelsey Starn, et al.
Investigational New Drugs|June 11, 2003
A phase I clinical trial of spicamycin derivative KRN5500 (NSC 650426) using a phase I accelerated titration "2B" designS M Gadgeel, R R Boinpally, L K Heilbrun, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2005
Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency)Dianne Keen-Kim, Joy B Redman, Reno U Alanes, et al.
Pediatric Research|October 28, 2009
Improving accuracy of Tay Sachs carrier screening of the non-Jewish population: analysis of 34 carriers and six late-onset patients with HEXA enzyme and DNA sequence analysisNoh Jin Park, Craig Morgan, Rajesh Sharma, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Characterization of a recurrent novel large duplication in the cystic fibrosis transmembrane conductance regulator geneFeras M Hantash, Joy B Redman, Dana Goos, et al.
Anti-Cancer Drugs|June 1, 1995
The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphomaA Maki, H Diwakaran, B Redman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 17, 2007
Molecular testing for Fragile X Syndrome: lessons learned from 119,232 tests performed in a clinical laboratoryCharles M Strom, Beryl Crossley, Joy B Redman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2014
A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinomaB Rini, B Redman, J A Garcia, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 12, 2010
Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysisCharles M Strom, Beryl Crossley, Arlene Buller-Buerkle, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Identification of cystic fibrosis variants by polymerase chain reaction/oligonucleotide ligation assayKaren M Schwartz, Lisa L Pike-Buchanan, Kasinathan Muralidharan, et al.
Human Genetics|December 20, 2005
Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screeningFeras M Hantash, Joy B Redman, Kelsey Starn, et al.
Investigational New Drugs|June 11, 2003
A phase I clinical trial of spicamycin derivative KRN5500 (NSC 650426) using a phase I accelerated titration "2B" designS M Gadgeel, R R Boinpally, L K Heilbrun, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2005
Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency)Dianne Keen-Kim, Joy B Redman, Reno U Alanes, et al.
Pediatric Research|October 28, 2009
Improving accuracy of Tay Sachs carrier screening of the non-Jewish population: analysis of 34 carriers and six late-onset patients with HEXA enzyme and DNA sequence analysisNoh Jin Park, Craig Morgan, Rajesh Sharma, et al.
Pageof 5